Folger Nolan Fleming Douglas Capital Management, Inc Abbott Laboratories Transaction History

Folger Nolan Fleming Douglas Capital Management, Inc

$873 Million
Q4 2024

A detailed history of Folger Nolan Fleming Douglas Capital Management, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Folger Nolan Fleming Douglas Capital Management, Inc holds 97,567 shares of ABT stock, worth $13.2 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares

97,567

Previous 101,418 3.8%

Holding current value

$13.2 Million

Previous $11.6 Million 4.56%

% of portfolio

1.26%

Previous 1.26%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	SELL	$111.93 - $119.39 $431,042 - $459,770	-3,851 Reduced 3.8%	97,567 $11 Million
Q3 2024 Oct 25, 2024	BUY	$100.07 - $118.13 $23,016 - $27,169	230 Added 0.23%	101,418 $11.6 Million
Q2 2024 Jul 09, 2024	SELL	$100.73 - $112.44 $196,222 - $219,033	-1,948 Reduced 1.89%	101,188 $10.5 Million
Q1 2024 Apr 12, 2024	BUY	$109.52 - $120.96 $649,563 - $717,413	5,931 Added 6.1%	103,136 $11.7 Million
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $76,751 - $93,950	-851 Reduced 0.87%	97,205 $10.7 Million
Q3 2023 Oct 25, 2023	SELL	$95.53 - $114.62 $5,158 - $6,189	-54 Reduced 0.06%	98,056 $9.5 Million
Q2 2023 Jul 27, 2023	BUY	$100.78 - $112.29 $311,410 - $346,976	3,090 Added 3.25%	98,110 $10.7 Million
Q1 2023 Apr 28, 2023	SELL	$96.86 - $114.01 $58,309 - $68,634	-602 Reduced 0.63%	95,020 $9.62 Million
Q4 2022 Jan 30, 2023	BUY	$95.06 - $111.52 $399,347 - $468,495	4,201 Added 4.6%	95,622 $10.5 Million
Q3 2022 Nov 01, 2022	BUY	$96.76 - $112.03 $95,502 - $110,573	987 Added 1.09%	91,421 $8.85 Million
Q2 2022 Jul 15, 2022	BUY	$102.07 - $123.37 $12,656 - $15,297	124 Added 0.14%	90,434 $9.83 Million
Q1 2022 Apr 27, 2022	BUY	$114.02 - $139.04 $123,141 - $150,163	1,080 Added 1.21%	90,310 $10.7 Million
Q4 2021 Feb 01, 2022	SELL	$115.53 - $141.46 $95,774 - $117,270	-829 Reduced 0.92%	89,230 $12.6 Million
Q3 2021 Oct 29, 2021	BUY	$116.66 - $129.06 $238,336 - $263,669	2,043 Added 2.32%	90,059 $10.6 Million
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $156,463 - $184,179	-1,479 Reduced 1.65%	88,016 $10.2 Million
Q1 2021 May 11, 2021	BUY	$108.84 - $128.23 $58,555 - $68,987	538 Added 0.6%	89,495 $10.7 Million
Q4 2020 Feb 05, 2021	SELL	$105.0 - $114.42 $109,935 - $119,797	-1,047 Reduced 1.16%	88,957 $9.74 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $43,529 - $52,862	475 Added 0.53%	90,004 $9.8 Million
Q2 2020 Aug 05, 2020	SELL	$76.57 - $98.0 $72,052 - $92,218	-941 Reduced 1.04%	89,529 $8.19 Million
Q1 2020 May 06, 2020	SELL	$62.82 - $91.86 $151,270 - $221,198	-2,408 Reduced 2.59%	90,470 $7.14 Million
Q4 2019 Feb 12, 2020	SELL	$78.51 - $87.4 $34,936 - $38,893	-445 Reduced 0.48%	92,878 $8.07 Million
Q3 2019 Nov 08, 2019	SELL	$81.84 - $88.74 $333,661 - $361,792	-4,077 Reduced 4.19%	93,323 $7.81 Million
Q2 2019 Aug 09, 2019	SELL	$72.88 - $85.0 $18,365 - $21,420	-252 Reduced 0.26%	97,400 $8.19 Million
Q1 2019 May 07, 2019	SELL	$66.22 - $80.06 $32,116 - $38,829	-485 Reduced 0.49%	97,652 $7.81 Million
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $5.97 Million - $6.76 Million	91,039 Added 1282.6%	98,137 $7.1 Million
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $5.94 Million - $6.73 Million	-90,612 Reduced 92.74%	7,098 $7.1 Million
Q3 2018 Nov 07, 2018	BUY	$60.81 - $73.36 $124,782 - $150,534	2,052 Added 2.15%	97,710 $7.17 Million
Q2 2018 Aug 08, 2018	BUY	$57.57 - $63.54 $17,558 - $19,379	305 Added 0.32%	95,658 $5.83 Million
Q1 2018 May 07, 2018	SELL	$56.27 - $63.62 $47,998 - $54,267	-853 Reduced 0.89%	95,353 $5.71 Million
Q4 2017 Feb 12, 2018	SELL	$53.68 - $57.47 $250,148 - $267,810	-4,660 Reduced 4.62%	96,206 $5.49 Million
Q3 2017 Nov 09, 2017	SELL	$48.06 - $53.64 $6,007 - $6,705	-125 Reduced 0.12%	100,866 $5.38 Million
Q2 2017 Aug 11, 2017	BUY	N/A	100,991	100,991 $4.91 Million

Others Institutions Holding ABT

# of Institutions

3,361

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Folger Nolan Fleming Douglas Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Folger Nolan Fleming Douglas Capital Management, Inc with notifications on news.

Account

Folger Nolan Fleming Douglas Capital Management, Inc Abbott Laboratories Transaction History